iShares U.S. Pharmaceuticals ETF (IHE)
IHE is a passive ETF by iShares tracking the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. IHE launched on May 5, 2006 and has a 0.42% expense ratio.
ETF Info
US4642888360
464288836
May 5, 2006
North America (U.S.)
1x
Dow Jones U.S. Select Pharmaceuticals Index
Multi-Cap
Growth
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in iShares U.S. Pharmaceuticals ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
iShares U.S. Pharmaceuticals ETF had a return of 10.54% year-to-date (YTD) and 17.96% in the last 12 months. Over the past 10 years, iShares U.S. Pharmaceuticals ETF had an annualized return of 4.71%, while the S&P 500 had an annualized return of 11.13%, indicating that iShares U.S. Pharmaceuticals ETF did not perform as well as the benchmark.
IHE
10.54%
-4.82%
2.10%
17.96%
8.12%
4.71%
^GSPC (Benchmark)
24.05%
1.08%
11.50%
30.38%
13.77%
11.13%
Monthly Returns
The table below presents the monthly returns of IHE, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2.95% | 6.67% | 0.45% | -5.65% | 2.62% | 1.33% | 2.94% | 6.73% | -2.60% | -2.15% | 10.54% | ||
| 2023 | -0.31% | -5.09% | -0.08% | 3.40% | -5.24% | 4.65% | 1.76% | 4.08% | -6.23% | -5.38% | 4.78% | 5.90% | 1.06% |
| 2022 | -4.56% | -3.62% | 6.23% | -3.32% | 3.53% | -1.08% | -0.58% | -7.55% | -3.24% | 6.80% | 3.47% | 0.06% | -4.87% |
| 2021 | 0.21% | -0.42% | -0.42% | 0.84% | 2.94% | 1.12% | 3.21% | 0.86% | -4.86% | 2.73% | -0.52% | 7.11% | 13.07% |
| 2020 | -0.56% | -9.15% | -6.53% | 13.24% | 3.30% | -2.05% | 2.43% | 6.33% | -1.99% | -2.76% | 7.52% | 5.26% | 13.66% |
| 2019 | 4.66% | 4.97% | -0.08% | -2.98% | -5.53% | 7.26% | -4.21% | -3.61% | 0.88% | 4.38% | 3.66% | 6.17% | 15.47% |
| 2018 | 1.94% | -4.65% | -1.33% | -2.20% | 3.20% | 1.97% | 6.69% | 4.99% | -0.76% | -9.20% | 3.39% | -10.45% | -7.77% |
| 2017 | 0.21% | 8.14% | -1.28% | 1.54% | -1.65% | 3.51% | 0.10% | -0.17% | 1.15% | -3.65% | 2.22% | 0.49% | 10.64% |
| 2016 | -12.31% | -3.96% | 0.83% | 3.05% | 3.86% | -1.28% | 7.78% | -4.30% | 0.53% | -8.73% | 2.40% | 1.49% | -11.75% |
| 2015 | 2.13% | 8.91% | 2.54% | -2.59% | 5.48% | -1.11% | 3.88% | -8.09% | -11.11% | 5.23% | 4.10% | 1.00% | 8.82% |
| 2014 | 2.31% | 9.26% | -3.82% | 2.04% | 1.50% | 3.54% | -3.60% | 5.67% | 2.27% | 4.02% | 4.51% | -0.52% | 29.90% |
| 2013 | 7.26% | 1.29% | 4.19% | 3.27% | 1.74% | -0.81% | 7.41% | -2.88% | 2.62% | 2.13% | 7.96% | 0.96% | 40.59% |
Expense Ratio
IHE features an expense ratio of 0.42%, falling within the medium range.
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of IHE is 48, suggesting that the investment has average results relative to other ETFs in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for iShares U.S. Pharmaceuticals ETF (IHE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
iShares U.S. Pharmaceuticals ETF provided a 1.58% dividend yield over the last twelve months, with an annual payout of $1.06 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $1.06 | $0.86 | $1.24 | $0.99 | $0.71 | $0.75 | $0.59 | $0.70 | $0.43 | $1.04 | $0.61 | $0.42 |
Dividend yield | 1.58% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% | 1.20% | 1.06% |
Monthly Dividends
The table displays the monthly dividend distributions for iShares U.S. Pharmaceuticals ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.29 | $0.00 | $0.00 | $0.36 | $0.00 | $0.00 | $0.93 | |
| 2023 | $0.00 | $0.00 | $0.22 | $0.00 | $0.00 | $0.20 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.13 | $0.86 |
| 2022 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.45 | $1.24 |
| 2021 | $0.00 | $0.00 | $0.21 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.26 | $0.99 |
| 2020 | $0.00 | $0.00 | $0.20 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.18 | $0.71 |
| 2019 | $0.00 | $0.00 | $0.19 | $0.00 | $0.00 | $0.18 | $0.00 | $0.00 | $0.21 | $0.00 | $0.00 | $0.17 | $0.75 |
| 2018 | $0.00 | $0.00 | $0.18 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.13 | $0.00 | $0.00 | $0.12 | $0.59 |
| 2017 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.31 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.12 | $0.70 |
| 2016 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.11 | $0.00 | $0.00 | $0.11 | $0.00 | $0.00 | $0.11 | $0.43 |
| 2015 | $0.00 | $0.00 | $0.09 | $0.00 | $0.00 | $0.13 | $0.00 | $0.00 | $0.13 | $0.00 | $0.00 | $0.70 | $1.04 |
| 2014 | $0.00 | $0.00 | $0.09 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.13 | $0.00 | $0.00 | $0.13 | $0.61 |
| 2013 | $0.10 | $0.00 | $0.00 | $0.11 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.11 | $0.42 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the iShares U.S. Pharmaceuticals ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the iShares U.S. Pharmaceuticals ETF was 38.20%, occurring on Mar 5, 2009. Recovery took 197 trading sessions.
The current iShares U.S. Pharmaceuticals ETF drawdown is 7.03%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -38.2% | May 23, 2007 | 450 | Mar 5, 2009 | 197 | Dec 14, 2009 | 647 |
| -32.24% | Jul 17, 2015 | 1179 | Mar 23, 2020 | 140 | Oct 9, 2020 | 1319 |
| -16.88% | Jul 8, 2011 | 22 | Aug 8, 2011 | 94 | Dec 20, 2011 | 116 |
| -16.03% | Apr 8, 2022 | 127 | Oct 10, 2022 | 331 | Feb 5, 2024 | 458 |
| -11.32% | Mar 24, 2010 | 53 | Jun 8, 2010 | 72 | Sep 20, 2010 | 125 |
Volatility
Volatility Chart
The current iShares U.S. Pharmaceuticals ETF volatility is 4.28%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.